Nanobiotix S.A.

NASDAQ:NBTX

Biotechnology

Healthcare
$26.90 -0.91%

-$0.33 today

Market cap
$1.37B
Beta
0.59
P/E (TTM)
-60.2
EPS (TTM)
-$0.51
52W Low $4.31High $57.14

Volume 0.04M

Average 0.08M

NBTX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Nanobiotix S.A.NASDAQ: NBTX

Weighted Avg Shares · Q4 FY2025 · quarter ended Dec 2025

Weighted avg shares grows 1.2% year over year

Q4 FY2025 weighted avg shares of 47.82M shares rose 1.2% year over year. Over 3 fiscal years it compounded at +11.1% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
47.82M— QoQ
Last fiscal yearDec 2025
47.82M+1.2% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.2%——
1 year+1.2%——
3-year CAGR+11.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
47.82M EUR
Year-over-year change
+1.2%
4-year CAGR
+8.3%

Weighted Avg Shares vs competitors

How NBTX compares with its peers on the latest reported figures

  • NBTX's FY2025 weighted avg shares of 47.82M shares is the 8th highest of the 11 companies compared; the peer median is 56.43M shares.
  • Its year-over-year change of +1.2% is the 10th highest of 11, against a peer median of +10.9%.
  • Over three fiscal years its annual growth of +11.1% compares with a peer median of +14.4%.
NBTX Competitors Peer median
Weighted Avg Shares for NBTX and competitors
Company Period LTM YoY 3-year CAGR
IBRXImmunityBio, Inc.LTM Sep 20261.03B +20.6%+32.0%
KURAKura Oncology, Inc.LTM Mar 202687.97M +1.1%+9.4%
SNDXSyndax Pharmaceuticals, Inc.LTM Mar 202686.55M +1.2%+12.5%
TYRATyra Biosciences, Inc.LTM Mar 202660.14M +2.0%+12.5%
BDTXBlack Diamond Therapeutics, Inc.LTM Mar 202656.95M +1.3%+16.2%
CADLCandel Therapeutics, Inc.LTM Mar 202655.91M +73.2%+22.5%
PBYIPuma Biotechnology, Inc.LTM Mar 202650.31M +2.7%+3.8%
NBTXNanobiotix S.A.FY202547.82M +1.2%+11.1%
AVBPArriVent BioPharma, Inc. Common StockLTM Mar 202640.11M +19.2%+4.7%
IMMXImmix Biopharma, Inc.LTM Mar 202634.62M +19.9%+33.4%
NVCTNuvectis Pharma, Inc.LTM Mar 202622.33M +21.4%+19.9%
Peer median (excluding NBTX) 56.43M+10.9%+14.4%

Competitors are the stored peer set for NBTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.65M4.78M36.21M(7.19M)29.64M
Cost of Revenue00000
Gross Profit2.65M4.78M36.21M(7.19M)29.64M
Gross Margin100.0%100.0%100.0%100.0%100.0%
Research & Development30.38M32.64M38.4M40.54M23.12M
Selling, General & Admin19.43M17.86M22.05M20.53M20.22M
Operating Expenses55.23M51.48M62.99M61.2M40.46M
Depreciation & Amortization1.56M1.5M551K592K1.5M
EBITDA(45.61M)(44.22M)(23.69M)(67.67M)(12.07M)
EBITDA Margin-1722.9%-925.8%-65.4%941.1%-40.7%
Operating Income(52.58M)(46.7M)(26.78M)(68.39M)(10.82M)
Operating Margin-1986.4%-977.8%-74.0%951.2%-36.5%
Interest Income0256K1.22M2.63M985K
Interest Expense699.49K5.84M7.98M8.09M10.4M
Other Income / Expenses5.58M(10.33M)(12.8M)361K(13.14M)
Income Before Tax(47M)(57.03M)(39.58M)(68.03M)(23.96M)
Pre-Tax Margin-1775.5%-1194.1%-109.3%946.2%-80.8%
Income Tax Expense5K10K120K101K3K
Net Income(47M)(57.04M)(39.7M)(68.13M)(23.96M)
Net Margin-1775.7%-1194.3%-109.6%947.6%-80.8%
EPS (Basic)(1.35)(1.64)(1.08)(1.44)(0.50)
EPS (Diluted)(1.35)(1.64)(1.08)(1.44)(0.50)
Weighted Avg Shares34.73M34.85M36.76M47.27M47.82M
Weighted Avg Shares (Diluted)34.73M34.85M36.93M47.27M47.82M

Nanobiotix S.A.

NASDAQ:NBTX

Intrinsic Alpha fair value

Locked

Current Price

$26.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.